Skip to main content

Table 7 Clinical phenotype study groups per GRADS

From: Clinical characteristics and organ system involvement in sarcoidosis: comparison of the University of Minnesota Cohort with other cohorts

Clinical Phenotype Study Groups n %
Group 1: Multiorgan 16 8.6
Group 2: Nonacute, Stage I, untreated 8 4.3
Group 3: Stage II-III, treated 44 23.5
Group 4: Stage II-III, untreated 23 12.3
Group 5: Stage IV, treated 2 1.1
Group 6: Stage IV, untreated 1 0.5
Group 7: Acute sarcoidosis 4 2.1
Group 8: Remitting 45 24.1
Group 9: Cardiac defining therapy 7 3.7
Unclassifiable per GRADS 37 19.8
 Stage 1, treated 8 4.3
 Stage 0, treated 27 14.4
 Stage 0, untreated 2 1.1